The complete therapeutic profile of ACE inhibitors relies on complex interactions between the renin-angiotensin system and other regulatory systems.
No takes yet. Share an insight, caveat, or question.
Confirms multifaceted ACE inhibitor actions beyond RAS blockade; leaves open dominant pathway contributions to outcomes.
Brunner et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: